Stocks Health care MDLN
NASDAQ · Health careMedline Inc. (MDLN)
Medline Inc. reported revenue of $28.4B in fiscal 2025. Net income was $1.2B, a net margin of 4.1%. Operating cash flow minus capital spending left $1.3B of free cash flow in fiscal 2025. At September 26, 2026 it held $2.3B in cash against $12.6B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.
Key facts about Medline Inc.
- Net worth
- Medline Inc. has a market value (market cap) of $53.8B at the latest share price, and shareholders' equity of $11.8B on its balance sheet at September 26, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $28.4B (+11.5% year on year), with net income of $1.2B.
- Cash flow
- In fiscal 2025 operations brought in $1.7B of cash; after $447M of capital spending, free cash flow was $1.3B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 26, 2026. Open on SEC EDGAR
- Next earnings report
- Medline Inc.'s next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Medline Inc. does
Medline manufactures and distributes medical supplies, clinical equipment, and surgical instruments. It supplies hospitals, surgery centers, nursing homes, and physician offices with items such as examination gloves, sterile drapes, wound care dressings, and patient care equipment. Its shares trade on NASDAQ under the ticker MDLN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $28.4B | $1.2B | -$0.01 | $1.3B |
| 2025 | n/a | $1.2B | n/a | n/a |
| 2025 | $25.5B | $1.2B | n/a | $1.4B |
| 2023 | $23.2B | $234M | n/a | $1.4B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where MDLN ranks in Health care
Latest SEC filings
What Medline Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026Passive stake changed SCHEDULE 13G/A
- November 4, 2026Quarterly report 10-Q · period to September 26, 2026Revenue rose 10% to $7.9B versus the same quarter last year; diluted EPS was $0.22.
- November 4, 2026
- October 30, 2026Passive stake changed SCHEDULE 13G/A
- October 21, 2026
- October 15, 2026
- August 11, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Passive stake (5% or more) SCHEDULE 13G
- August 5, 2026Quarterly report 10-Q · period to June 27, 2026Revenue rose 12% to $7.7B versus the same quarter last year; diluted EPS was $0.07.
What is MDLN worth? A DCF from its reported cash flow
Insider trades
What the people running Medline Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $1.05B worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 8, 2026 | GIC Private Ltd10% owner | Soldindirect | 7,816,987 | $274.8M |
| October 6, 2026 | GIC Private Ltd10% owner | Sold | 2,088,987 | $73.2M |
| October 6, 2026 | GIC Private Ltd10% owner | Soldindirect | 7,183,013 | $251.8M |
| October 5, 2026 | GIC Private Ltd10% owner | Sold | 1,688,690 | $60.4M |
| October 2, 2026 | GIC Private Ltd10% owner | Sold | 2,570,999 | $90.9M |
| October 2, 2026 | GIC Private Ltd10% owner | Soldindirect | 7,146,941 | $245.4M |
| August 14, 2026 | GIC Private Ltd10% owner | Sold | 100,000 | $3.6M |
| August 13, 2026 | GIC Private Ltd10% owner | Sold | 1,500,000 | $53.7M |
Who owns MDLN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Mozart Holdco, Inc.13G, passive | 22.4% | February 13, 2026 |
| Bma Viii L.L.C.13G, passive with 15 related filers | 16.5% | August 7, 2026 |
| Hellman & Friedman Investors X, L.P.13G, passive with 8 related filers | 16% | August 11, 2026 |
| GIC Private Limited13G, passive with 2 related filers | 8.49% | November 6, 2026 |
| Fmr LLC13G, passive with 1 related filers | 5.5% | August 6, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 406 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Carlyle Group Inc. | 187,083,713 | 0 |
| H&F Corporate Investors X, Ltd. | 70,874,326 | -15,599,171 |
| Fmr LLC | 46,963,203 | +10,407,002 |
| Capital Research Global Investors | 39,963,790 | +16,802,120 |
| Invesco Ltd. | 38,346,937 | +17,383,322 |
| BlackRock, Inc. | 26,393,587 | +9,469,927 |
| Morgan Stanley | 21,605,662 | +5,902,759 |
| Lone Pine Capital LLC | 20,968,367 | +9,179,211 |
| Massachusetts Financial Services Co | 19,888,806 | +8,319,490 |
| Vanguard Capital Management LLC | 17,816,057 | +3,086,376 |
| Vanguard Portfolio Management LLC | 16,781,031 | +2,630,279 |
| Egerton Capital (UK) LLP | 16,470,884 | +12,105,082 |
| Jupiter Topco LLC | 15,858,400 | new |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 11,956,905 | +7,572,176 |
| Baillie Gifford & Co | 11,343,036 | +1,367,261 |
| Norges Bank | 8,475,413 | new |
| State Street Corp | 8,447,035 | +3,624,652 |
| Geode Capital Management, LLC | 7,948,506 | +1,690,234 |
| SurgoCap Partners LP | 7,487,507 | +1,412,342 |
| Wcm Investment Management, LLC | 7,397,650 | +178,919 |
Insiders
25 insiders reported holding 1,406,239,798 shares in total, about $57.53B at the last price.
| Holder | Shares |
|---|---|
| Mozart Holdco, Inc.10% owner | 234,308,304 |
| TC Group VII S1, L.L.C.10% owner | 215,303,036215,303,036 held indirectly |
| Carlyle Mozart Coinvestment Holdings, L.P.10% owner | 203,208,807187,083,713 held indirectly |
| TC Group Cayman Investment Holdings, L.P.10% owner | 187,083,713187,083,713 held indirectly |
| CP Circle ML Holdco GP, LLC10% owner | 187,083,713187,083,713 held indirectly |
| Carlyle Group Inc.10% owner | 187,083,713187,083,713 held indirectly |
| Hellman & Friedman Capital Partners X (Parallel), L.P.10% owner | 88,831,04788,831,047 held indirectly |
| GIC Private Ltd10% owner | 85,862,31269,408,506 held indirectly |
| BX Mozart ML-1 Holdco L.P.10% owner | 8,257,5028,257,502 held indirectly |
| Mills Andrew J.Director | 2,616,8612,616,861 held indirectly |
Questions about MDLN
What does Medline Inc. do?
Medline manufactures and distributes medical supplies, clinical equipment, and surgical instruments. It supplies hospitals, surgery centers, nursing homes, and physician offices with items such as examination gloves, sterile drapes, wound care dressings, and patient care equipment. Its shares trade on NASDAQ under the ticker MDLN.
What is Medline Inc.'s net worth?
Medline Inc. has a market value (market cap) of $53.8B at the latest share price, and shareholders' equity of $11.8B on its balance sheet at September 26, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Medline Inc. profitable?
Yes. In fiscal 2025 it reported net income of $1.2B on revenue of $28.4B, a net margin of 4.1%.
How much revenue does Medline Inc. make?
In fiscal 2025 Medline Inc. reported revenue of $28.4B.
When did Medline Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 26, 2026. Its newest filing of any kind is the passive stake changed from November 6, 2026.
When is Medline Inc.'s next earnings report?
Medline Inc.'s next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare MDLN with
Follow MDLN
Get an email when Medline Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Medline Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.